This plan amendment adds establishes a cost-based reimbursement methodology for NC Select Drugs, including Cell and Gene Therapies administered in the Hospital Inpatient, Hospital Outpatient, and Professional Outpatient settings.
State
Topics
Approval Date
Effective Date
File 1 - Approval Document Media